BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12804605)

  • 1. Solution structure and biological activity of recombinant salmon calcitonin S-sulfonated analog.
    Wang Y; Dou H; Cao C; Zhang N; Ma J; Mao J; Wu H
    Biochem Biophys Res Commun; 2003 Jun; 306(2):582-9. PubMed ID: 12804605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution structure of salmon calcitonin.
    Meyer JP; Pelton JT; Hoflack J; Saudek V
    Biopolymers; 1991 Feb; 31(2):233-41. PubMed ID: 2043752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of a human calcitonin analog elucidated by NMR and distance geometry calculations.
    Katahira R; Doi M; Kyogoku Y; Yamada-Nosaka A; Yamasaki K; Takai M; Kobayashi Y
    Int J Pept Protein Res; 1995 Apr; 45(4):305-11. PubMed ID: 7601602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural determinants of salmon calcitonin bioactivity: the role of the Leu-based amphipathic alpha-helix.
    Andreotti G; Méndez BL; Amodeo P; Morelli MA; Nakamuta H; Motta A
    J Biol Chem; 2006 Aug; 281(34):24193-203. PubMed ID: 16766525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating calcitonin fibrillogenesis: an antiparallel alpha-helical dimer inhibits fibrillation of salmon calcitonin.
    Andreotti G; Motta A
    J Biol Chem; 2004 Feb; 279(8):6364-70. PubMed ID: 14594801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of elcatonin in solution.
    Ogawa K; Nishimura S; Doi M; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1994 Jun; 222(2):659-66. PubMed ID: 8020504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of human and salmon calcitonin secondary structure in solutions with low dielectric constants.
    Arvinte T; Drake AF
    J Biol Chem; 1993 Mar; 268(9):6408-14. PubMed ID: 8454613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution conformation of salmon calcitonin in sodium dodecyl sulfate micelles as determined by two-dimensional NMR and distance geometry calculations.
    Motta A; Pastore A; Goud NA; Castiglione Morelli MA
    Biochemistry; 1991 Oct; 30(43):10444-50. PubMed ID: 1931969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational analysis of human calcitonin in solution.
    Ogawa K; Nishimura S; Doi M; Takashima H; Nishi Y; Yoshida T; Ohkubo T; Kobayashi Y
    J Pept Sci; 2006 Jan; 12(1):51-7. PubMed ID: 15948142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NMR investigations of structural and dynamics features of natively unstructured drug peptide - salmon calcitonin: implication to rational design of potent sCT analogs.
    Rawat A; Kumar D
    J Pept Sci; 2013 Jan; 19(1):33-45. PubMed ID: 23208874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequential 1H NMR assignment and secondary structure determination of salmon calcitonin in solution.
    Motta A; Morelli MA; Goud N; Temussi PA
    Biochemistry; 1989 Oct; 28(20):7996-8002. PubMed ID: 2605169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure of human calcitonin in membrane-mimetic environment: the role of the amphipathic helix.
    Motta A; Andreotti G; Amodeo P; Strazzullo G; Castiglione Morelli MA
    Proteins; 1998 Aug; 32(3):314-23. PubMed ID: 9715908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hydrophobic moment of the amphipathic helix of salmon calcitonin and biological potency.
    Epand RM; Seyler JK; Orlowski RC
    Eur J Biochem; 1986 Aug; 159(1):125-7. PubMed ID: 3743567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of increased length and intact capping sequences to the conformational preference for helix in a 31-residue peptide from the C terminus of myohemerythrin.
    Reymond MT; Huo S; Duggan B; Wright PE; Dyson HJ
    Biochemistry; 1997 Apr; 36(17):5234-44. PubMed ID: 9136885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deletion sequences of salmon calcitonin that retain the essential biological and conformational features of the intact molecule.
    Epand RM; Epand RF; Stafford AR; Orlowski RC
    J Med Chem; 1988 Aug; 31(8):1595-8. PubMed ID: 3397998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between biological activities and conformational properties for human, salmon, eel, porcine calcitonins and Elcatonin elucidated by CD spectroscopy.
    Siligardi G; Samorí B; Melandri S; Visconti M; Drake AF
    Eur J Biochem; 1994 May; 221(3):1117-25. PubMed ID: 8181470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformation analysis of eel calcitonin--comparison with the conformation of elcatonin.
    Ogawa K; Nishimura S; Uchiyama S; Kobayashi K; Kyogoku Y; Hayashi M; Kobayashi Y
    Eur J Biochem; 1998 Oct; 257(2):331-6. PubMed ID: 9826177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution.
    Amodeo P; Motta A; Strazzullo G; Castiglione Morelli MA
    J Biomol NMR; 1999 Feb; 13(2):161-74. PubMed ID: 10070757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological potency of a series of analogues of human calcitonin correlates with their interactions with phospholipids.
    Epand RF; Orlowski RC; Epand RM
    Biopolymers; 2004; 76(3):258-65. PubMed ID: 15148685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational flexibility and biological activity of salmon calcitonin.
    Epand RM; Epand RF; Orlowski RC; Seyler JK; Colescott RL
    Biochemistry; 1986 Apr; 25(8):1964-8. PubMed ID: 3707923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.